Skip to main content
Caplight Logo









ExCellThera

ExCellThera

Private
MontrealHealthcare & Life Scienceshttps://excellthera.com/

Last Round

Grant

Sep 20, 2022

Total Funding Raised

$620,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ExCellThera is a biotechnology company that develops and commercializes advanced cell expansion and engineering solutions for the treatment of blood cancers and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Non-AI

Keywords

hematopoietic stem cellHSCcell expansioncell therapycord bloodstem cell therapyallogeneic transplantationex vivo expansioncell therapy manufacturingregenerative medicinesmall moleculehematological malignancybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExCellThera Comparables

Compare ExCellThera with similar companies based on industry and business-model similarity.

ExCellThera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nohla Therapeutics
83%
Celaid Therapeutics
79%
HexemBio
79%

ExCellThera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 20, 2022
GrantAug 7, 2020
GrantApr 5, 2017
AcceleratorJun 15, 2015

Key People

Founding team and executive leadership

David Millette

Chief Executive Officer

Executive Team

Eric Martel

CFO

Executive Team

MSc Nathalie Bourgouin

Chief Operating Officer, VP, Quality and Compliance

Executive Team

ExCellThera Investors

Notable investors and investment history

ExCellThera investors
InvestorRounds
IRICoRGrant, Accelerator
CCRMAccelerator
California Institute for Regenerative MedicineGrant
Next Generation Manufacturing Canada (NGen)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 1179% MoM, from 75 to 959.

ExCellThera Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ExCellThera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ExCellThera's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range15
Year Founded2014
Last FundingSep 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?